Cardinal Health (NYSE:CAH) released its quarterly earnings data on Thursday. The company reported $1.11 EPS for the quarter, topping the consensus estimate of $0.93 by $0.18, Bloomberg Earnings reports. The firm had revenue of $37.35 billion for the quarter, compared to analysts’ expectations of $36.70 billion. During the same quarter in the previous year, the business earned $1.01 earnings per share. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year. Cardinal Health updated its FY 2020 guidance to $4.85-5.10 EPS and its FY20 guidance to $4.85 to $5.10 EPS.
Shares of NYSE:CAH opened at $44.35 on Friday. Cardinal Health has a 12-month low of $41.03 and a 12-month high of $58.31. The firm has a fifty day moving average of $46.02. The stock has a market cap of $12.74 billion, a P/E ratio of 8.40, a PEG ratio of 1.34 and a beta of 1.28. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.07 and a quick ratio of 0.54.
Large investors have recently made changes to their positions in the company. WP Advisors LLC purchased a new position in shares of Cardinal Health in the 1st quarter valued at $26,000. Bremer Bank National Association purchased a new position in shares of Cardinal Health in the 1st quarter valued at $27,000. Financial Gravity Wealth Inc. increased its holdings in shares of Cardinal Health by 258.5% in the 2nd quarter. Financial Gravity Wealth Inc. now owns 692 shares of the company’s stock valued at $33,000 after acquiring an additional 499 shares during the period. SRS Capital Advisors Inc. purchased a new position in shares of Cardinal Health in the 2nd quarter valued at $36,000. Finally, Trustcore Financial Services LLC boosted its position in shares of Cardinal Health by 80.6% in the 2nd quarter. Trustcore Financial Services LLC now owns 784 shares of the company’s stock worth $37,000 after purchasing an additional 350 shares in the last quarter. Institutional investors and hedge funds own 89.23% of the company’s stock.
A number of research analysts have recently issued reports on the company. ValuEngine upgraded Cardinal Health from a “strong sell” rating to a “sell” rating in a report on Thursday, May 9th. Guggenheim assumed coverage on Cardinal Health in a report on Wednesday, April 17th. They issued a “neutral” rating and a $51.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating and seven have issued a hold rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $54.63.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Featured Story: Reverse Stock Split
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.